Uranium-233

From Wikipedia, the free encyclopedia

Uranium-233 is a fissile artificial isotope of uranium, which is proposed as a nuclear fuel. It has a half-life of 160,000 years.

Uranium-233 is produced by the neutron irradiation of thorium-232. When thorium-232 absorbs a neutron, it becomes thorium-233, which has a half-life of only 22 minutes. Thorium-233 decays into protactinium-233 through beta decay. Protactinium-233 has a half life of 27 days and beta decays into uranium-233.

Breeding uranium-233 from thorium feedstock is the long-term strategy of the nuclear power program of India, which has substantial thorium reserves. This can in theory be accomplished using either fast or thermal reactors, unlike uranium-based fuel cycles which require the superior neutron economy of a fast reactor in order to breed, that is to produce more fissile material than is consumed. Outside of India, interest in the thorium-based fuel cycle is not great, although the world's reserves of thorium are three times those of uranium.

It is also possible to use uranium-233 as the fuel of a nuclear weapon. This has been done on occasion. The United States first tested a U-233 bomb core as part of Operation Teapot in 1955, but in general fabrication of a bomb from U-233 presents difficulties beyond that of assembling one from uranium-235; production of U-233 invariably produces some U-232 as well, and the decay chain of U-232 yields a lot of alpha and gamma emitters, making it a more difficult material to handle safely.

The radioisotope bismuth-213, a promising new radioisotope for cancer treatment, is a decay product of uranium-233. Bismuth-213 has promise for the treatment of certain types of cancer, including acute myeloid leukemia and cancers of the pancreas, kidneys and other organs.

Uranium-232	Isotopes of Uranium	Uranium-234
Produced from: Plutonium-237 (α) Neptunium-233 (β+) Protactinium-233 (β-)	Decay chain	Decays to: Thorium-229 (α)